Perifosine: Phase I started

Aeterna Zentaris said partner Yakult began an open-label, Japanese Phase I trial to evaluate 50 mg oral perifosine daily in 21-day cycles in combination

Read the full 244 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE